201 consecutive cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in a single Asian tertiary centre

Does early post-operative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference?

(2016) Grace Hwei Ching Tan et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Dissemination from Small Bowel Malignancy: Results from a Single Specialized Center

(2015) Yang Liu et al.   ANNALS OF SURGICAL ONCOLOGY

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus

(2015) Yang Liu et al.   ANNALS OF SURGICAL ONCOLOGY

Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours

(2015) A.C. Lord et al.   EJSO

Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study

(2014) J. Spiliotis et al.   ANNALS OF SURGICAL ONCOLOGY

Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival for Patients with Peritoneal Carcinomatosis from Colorectal Cancer: A Phase II Study from a Chinese Center

(2014) Chao-Qun Huang et al.   PLoS One

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Asian Patients: 100 Consecutive Patients in a Single Institution

(2013) Melissa Ching Ching Teo et al.   ANNALS OF SURGICAL ONCOLOGY

Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis

(2012) L. H. Iversen et al.   BRITISH JOURNAL OF SURGERY

Survival Benefit of Adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the Different Time-points of Treatment of Ovarian Cancer: Review of Evidence

(2012) Stefaan Mulier et al.   CURRENT PHARMACEUTICAL DESIGN

The Importance of the Learning Curve and Surveillance of Surgical Performance in Peritoneal Surface Malignancy Programs

(2012) Shigeki Kusamura et al.   Surgical Oncology Clinics of North America

A new standard of care for the management of peritoneal surface malignancy

(2011) F. Mohamed et al.   Current Oncology

8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer

(2008) Vic J. Verwaal et al.   ANNALS OF SURGICAL ONCOLOGY

Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer

(2008) Angelo Di Giorgio et al.   CANCER

Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy

(2008) Rami Younan et al.   JOURNAL OF SURGICAL ONCOLOGY